Literature DB >> 13696648

Urinary excretion of catecholamines and their metabolites in pheochromocytoma.

J R CROUT, J J PISANO, A SJOERDSMA.   

Abstract

Entities:  

Keywords:  CATECHOLAMINES/urine; PHEOCHROMOCYTOMA/urine

Mesh:

Substances:

Year:  1961        PMID: 13696648     DOI: 10.1016/0002-8703(61)90609-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  21 in total

1.  CHEMICAL TESTS FOR PHAEOCHROMOCYTOMA.

Authors:  J KELLEHER; G WALTERS; R ROBINSON; P SMITH
Journal:  J Clin Pathol       Date:  1964-07       Impact factor: 3.411

2.  TURNOVER AND METABOLISM OF CATECHOLAMINES IN PATIENTS WITH PHEOCHROMOCYTOMA.

Authors:  J R CROUT; A SJOERDSMA
Journal:  J Clin Invest       Date:  1964-01       Impact factor: 14.808

3.  [On the demonstration of 3-methoxy-4-hydroxy-mandelic acid in the urine].

Authors:  E SCHMID; N HENNING
Journal:  Klin Wochenschr       Date:  1963-06-01

4.  Effects of catechol on human subjects: a field survey.

Authors:  I Hirosawa; G Asaeda; H Arizono; S Shimbo; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1976-06-03       Impact factor: 3.015

Review 5.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

Review 6.  Catecholamine-secreting tumours.

Authors:  M Sandler
Journal:  Proc R Soc Med       Date:  1967-08

7.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?

Authors:  R T Peaston; L C Lai
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

9.  Phaeochromocytoma with nocturnal elevation of blood pressure.

Authors:  T Yamamoto; T Jo; T Ishibashi
Journal:  Postgrad Med J       Date:  1978-01       Impact factor: 2.401

10.  PLASMA CLEARANCE OF DL-BETA-H3-NOREPINEPHRINE IN NORMAL HUMAN SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION.

Authors:  S E GITLOW; M MENDLOWITZ; E K WILK; S WILK; R L WOLF; N E NAFTCHI
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.